1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow KAE609: new trials by email Literature Review of KAE609 trials Research Report on KAE609
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects KAE609, Placebo - Malaria | Phase 1 | Completed | Novartis Pharmaceuticals | 57 | 2020-07-22 | 2021-12-13 |
| Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos KAE609, Piperaquine Phosphate - Plasmodium Falciparum Malaria | Phase 1 | Terminated | Novartis Pharmaceuticals | 8 | 2015-07-01 | 2019-07-23 |
Malaria (2) · Malaria, Falciparum (1)
Australia (1) · Belgium (1)
2019 (1)